Metabolic syndrome and endocrine dysfunctions after HSCT in children

Pediatric Transplantation

Volumn 16, Issue 8, 2012, Pages 872-878

  Bajwa, Rajinder ^a   Skeens, Micah ^a   Garee, Amy ^a   Miao, Yongjie ^a   Soni, Sandeep ^a   Pietryga, Daniel ^a   Gross, Thomas ^a   Termuhlen, Amanda ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

dyslipidemia; endocrine dysfunction; long term complications; metabolic syndrome

Indexed keywords

BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; LEVOTHYROXINE; MELPHALAN; TADALAFIL; THIOTEPA;

ADOLESCENT; ADRENAL INSUFFICIENCY; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AMENORRHEA; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; DISEASE ASSOCIATION; DRUG MEGADOSE; DYSLIPIDEMIA; ENDOCRINE DISEASE; ERECTILE DYSFUNCTION; FEMALE; GROWTH HORMONE DEFICIENCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPOGONADISM; HYPOTHYROIDISM; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX RATIO; SHORT STATURE; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; ENDOCRINE SYSTEM DISEASES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84868696450     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12002     Document Type: Article

References (23)

1. Leung W, Ahn H, Rose SR, et al. A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation. Medicine (Baltimore) 2007: 86: 215-224.
2. Hows JM, Passweg JR, Tichelli A, et al. Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors. Bone Marrow Transplant 2006: 38: 799-805.
3. Bresters D, Van Gils IC, Kollen WJ, et al. High burden of late effects after haematopoietic stem cell transplantation in childhood: A single-centre study. Bone Marrow Transplant 2010: 45: 79-85.
4. Baker KS, Ness KK, Weisdorf D, et al. Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: A report from the Bone Marrow Transplant Survivor Study. Leukemia 2010: 24: 2039-2047.
5. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005: 112: 2735-2752.
6. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009: 120: 1640-1645.
7. Tailor AM, Peeters PH, Norat T, Vineis P, Romaguera D,. An update on the prevalence of the metabolic syndrome in children and adolescents. Int J Pediatr Obes 2010: 5: 202-213.
8. Annaloro C, Usardi P, Airaghi L, et al. Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant 2008: 41: 797-804.
9. Taskinen M, Saarinen-Pihkala UM, Hovi L, Lipsanen-Nyman M,. Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 2000: 356: 993-997.
10. Tichelli A, Bucher C, Rovõ A, et al. Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood 2007: 110: 3463-3471.
11. Zimmet P, Alberti KG, Kaufman F, et al. The metabolic syndrome in children and adolescents-an IDF consensus report. Pediatr Diabetes 2007: 8: 299-306.
12. Alberti KG, Zimmet PZ,. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998: 15: 539-553.
13. Cohen A, Békássy AN, Gaiero A, et al. Endocrinological late complications after hematopoietic SCT in children. Bone Marrow Transplant 2008: 41 (Suppl 2): S43-S48.
14. Sanders JE,. Growth and development after hematopoietic cell transplant in children. Bone Marrow Transplant 2008: 41: 223-227.
15. Baker KS, Ness KK, Steinberger J, et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: A report from the bone marrow transplantation survivor study. Blood 2007: 109: 1765-1772.
16. Shalitin S, Phillip M, Stein J, Goshen Y, Carmi D, Yaniv I,. Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence. Bone Marrow Transplant 2006: 37: 1109-1117.
17. Steinberger J, Sinaiko AR, Kelly AS, et al. Cardiovascular risk and insulin resistance in childhood cancer survivors. J Pediatr 2012: 160: 494-499.
18. Mostoufi-Moab S, Ginsberg JP, Bunin N, et al. Body composition abnormalities in long-term survivors of pediatric hematopoietic stem cell transplantation. J Pediatr 2012: 160: 122-128.
19. Baker KS, Chow E, Steinberger J,. Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation. Bone Marrow Transplant 2012: 47: 619-625.
20. Reilly JJ, Kelly J, Wilson DC,. Accuracy of simple clinical and epidemiological definitions of childhood obesity: Systematic review and evidence appraisal. Obes Rev 2010: 11: 645-655.
21. Ruble K, Hayat M, Stewart KJ, Chen A,. Body composition after bone marrow transplantation in childhood. Oncol Nurs Forum 2012: 39: 186-192.
22. Jung MH, Cho KS, Lee JW, et al. Endocrine complications after hematopoietic stem cell transplantation during childhood and adolescence. J Korean Med Sci 2009: 24: 1071-1077.
23. Ness KK, Leisenring W, Goodman P, et al. Assessment of selection bias in clinic-based populations of childhood cancer survivors: A report from the childhood cancer survivor study. Pediatr Blood Cancer 2009: 52: 379-386.